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Objective: Delayed ischemic neurological deﬁcit (DIND) contributes to poor outcome in subarachnoid hemorrhage
(SAH) patients. Because there is continuing uncertainty as to whether proximal cerebral artery vasospasm is the
only cause of DIND, other processes should be considered. A potential candidate is cortical spreading depolar-
ization (CSD)-induced hypoxia. We hypothesized that recurrent CSDs inﬂuence cortical oxygen availability.
Methods: Centers in the Cooperative Study of Brain Injury Depolarizations (COSBID) recruited 9 patients with
severe SAH, who underwent open neurosurgery. We used simultaneous, colocalized recordings of electrocorticog-
raphy and tissue oxygen pressure (ptiO2) in human cerebral cortex. We screened for delayed cortical infarcts by
using sequential brain imaging and investigated cerebral vasospasm by angiography or time-of-ﬂight magnetic
resonance imaging.
Results: In a total recording time of 850 hours, 120 CSDs were found in 8 of 9 patients. Fifty-ﬁve CSDs (46%)
were found in only 2 of 9 patients, who later developed DIND. Eighty-nine (75%) of all CSDs occurred between
the 5th and 7th day after SAH, and 96 (80%) arose within temporal clusters of recurrent CSD. Clusters of CSD
occurred simultaneously, with mainly biphasic CSD-associated ptiO2 responses comprising a primary hypoxic and a
secondary hyperoxic phase. The frequency of CSD correlated positively with the duration of the hypoxic phase and
negatively with that of the hyperoxic phase. Hypoxic phases signiﬁcantly increased stepwise within CSD clusters;
particularly in DIND patients, biphasic ptiO2 responses changed to monophasic ptiO2 decreases within these
clusters. Monophasic hypoxic ptiO2 responses to CSD were found predominantly in DIND patients.
Interpretation: We attribute these clinical ptiO2 ﬁndings mainly to changes in local blood ﬂow in the cortical
microcirculation but also to augmented metabolism. Besides classical contributors like proximal cerebral vaso-
spasm, CSD clusters may reduce O2 supply and increase O2 consumption, and thereby promote DIND.
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erebral vasospasm of large proximal arteries is re-
garded as the prime cause of delayed ischemic neu-
rological deficit (DIND) after subarachnoid hemorrhage
(SAH). It is, however, only 1 possible contributor to
DIND.
1,2 Thus, a search is required for alternative or ad-
ditional mechanisms to explain delayed deterioration after
SAH.
1,3 DIND has recently been associated with cortical
spreading depolarization (CSD),
4 a striking electrophysi-
ological phenomenon that was originally described as
“cortical spreading depression” by Lea ˜o in 1944.
5,6 CSD
is a self-propagating wave of neuronal and glial depolar-
ization that has been extensively investigated in ani-
mals.
6–8 A series of recent clinical studies using subdural
electrocorticography (ECoG) filtered to include low fre-
quencies provides direct and unequivocal electrophysio-
logical evidence for the existence of CSDs in neuro-
trauma,
9 malignant middle cerebral artery infarction,
10
and SAH.
4 These studies suggest that CSD may be a gen-
eral phenomenon leading to secondary deterioration in
various clinical entities.
11
CSD waves are accompanied by propagating failure
of brain ion homeostasis resulting in an interruption of
cortical function.
7 Under physiological conditions, the
brain is able fully to recover from the metabolic challenge
of reestablishing ion homeostasis during the repolarization
phase of CSD without measurable tissue damage.
12 This
ability is mainly achieved by a compensatory vasodilatory
response coupled to CSD. In contrast, recurrent CSDs
emerging spontaneously in metabolically compromised
tissue, such as in the ischemic penumbra (in this situation
termed peri-infarct depolarizations, [PIDs])
13 or after
SAH,
4 irreversibly damage brain tissue at risk and thereby
may lead to lesion growth.
10,14,15 Animal experiments
have suggested that, under such conditions of impaired
metabolic status, the vasodilatory response to CSD
switches from a compensatory vasodilatory response to an
inverse, vasoconstrictive neurovascular coupling, resulting
in cortical spreading ischemia (CSI).
16–19 In a rat model,
it has been hypothesized that, in principle, CSD activates
both vasoconstriction and vasodilatation in a biphasic
fashion, the ratio between the 2 being shifted toward va-
soconstriction by ischemic/hypoxic tissue conditions.
20
Recently, combined recordings of regional cerebral blood
flow (CBF) and ECoG using subdural optoelectrode
strips have provided evidence that delayed ischemic stroke
is associated with CSI in patients with SAH.
15 To our
knowledge, this is the first detailed report of continuously
corecorded tissue oxygen pressure (ptiO2) and CSD in hu-
man cerebral cortex. We hypothesized that CSDs, in par-
ticular if they occur in temporal clusters, reduce cortical
oxygen availability.
Materials and Methods
The study was designed and performed as a substudy within the
Cooperative Study of Brain Injury Depolarizations (COSBID)
study group. Patients or their relatives gave written consent for
study inclusion. The study was approved by the local ethics
committees of the Universities of Cologne and Mannheim/Hei-
delberg. At these centers, 9 patients with acute SAH due to
spontaneous rupture of an intracranial aneurysm were studied,
where imaging
21 and clinical
4,22,23 characteristics indicated a
high risk of DIND development. Patients were treated accord-
ing to German guidelines for aneurysmal SAH (Association of
the Scientific Medical Societies in Germany; see www.AWM-
F.org). If a low level of consciousness required it, patients were
ventilated and sedated using midazolam  fentanyl/sufentanil
(n  8). Patient 3 was partly ventilated and sedated, and
breathed spontaneously in the later part of the monitoring.
When craniotomy was required either for aneurysm clipping, or
for intracranial hemorrhage evacuation in patients in whom the
aneurysm was coiled, electrode and ptiO2 probe implantations
were performed before closure of the craniotomy, for later re-
cording of these variables.
Implantation of ECoG Strip Electrodes and
ptiO2 Probes
The ECoG strip electrode (Ad-Tech Medical, Racine, WI) was
placed on the cerebral cortex as reported previously (Fig 1).
4 In
addition, a Clark-type probe for ptiO2 monitoring (Licox CC1-
SB, Integra Neurosciences, Andover, UK) was inserted in the
cerebral cortex. The 0.5mm thin probe was placed adjacent to
the ECoG strip (8mm) between the single electrodes (see Fig
1D, L). It samples a tissue compartment of 7.1 to 15mm
2.
24
Neither bleeding nor infection was seen associated with place-
ment or removal of either the ECoG electrode strip or the ptiO2
probe.
Electrocorticography and Data Analysis
The subdural ECoG was recorded and analyzed following a
standardized COSBID protocol (see Supplementary Patients and
Methods online for brief description).
4,9,10 Figure 2A shows an
original ECoG recording. We distinguished between single
CSDs (interval between 2 CSDs 2 hours) and those that oc-
curred repetitively within clusters with rather short intervals be-
tween consecutive CSDs (2 hours) and with only small vari-
ations in interval length (10%) in individual CSD clusters.
We further differentiated between the 1st, 2nd, 3rd, and 4th or
later CSD positions within the cluster.
Brain Tissue Oxygen Partial Pressure
Monitoring and Data Analyses
ptiO2 was continuously quantified in the cortical tissue that was
overlaid by the 6-contact-ECoG strip electrodes (compare Fig.
3). Because of the spatial distance between ECoG electrode and
ptiO2 probe (8mm), ptiO2 changes were accepted as coregis-
trations in a small range of 6 minutes around time points of
CSD appearance. Such spatial distance may lead to a small time-
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as significant ptiO2 responses if a rapid ( 120 seconds) ptiO2
deviation from the baseline (2mmHg) was detected.
Because ptiO2 is closely correlated with local CBF,
15,24,25
we classified the ptiO2 alterations (Fig 4A) according to classifi-
cations used for CBF responses to CSDs: monophasic increases,
biphasic alterations with an initial decrease and a secondary in-
crease, and monophasic decreases.
19 CSD-associated ptiO2 re-
sponse analysis was also performed using the matching ECoG
event criteria with differentiation between the 1st, 2nd, 3rd, and
4th or later temporal rank of the ptiO2 response within the clus-
ter. Because not all SAH patients revealed clusters with such
numerous CSD repetitions (4), in addition, we separately
scrutinized patients with long clusters.
As elements of the CSD-associated ptiO2 response (see Fig
2B), we determined the preresponse ptiO2 baseline, the mini-
mum and the duration of the ptiO2 decrease, and the maximum
and the duration of the ptiO2 increase. We analyzed the curve
integrals expressed as arbitrary units (aU) of hypoxic (INThypo)
and hyperoxic (INThyper)p tiO2 responses, and assessed the por-
tions from start at baseline to minimum as descent integral (de-
scINThypo) and to maximum as ascent integral (ascINThyper),
respectively. The latter parameter was chosen because the time
needed for return to baseline was quite variable, in particular
after reaching the secondary maxima.
Digital Subtraction Angiography and Time-of-
Flight Magnet Resonance Imaging
In 7 of 9 patients, we had the logistic possibilities to investigate
proximal vasospasm by performing digital subtraction (DS) an-
giography or time-of-flight magnetic resonance imaging (MRI)
on the 6th to 9th day after SAH.
General Intensive Care Unit Monitoring
See Supplementary Patients and Methods online.
Statistical Analysis
Results are expressed (if not otherwise stated) as median (1st,
3rd quartile); when necessary, ranges are also given. For non-
parametric comparison between variables of ECoG and/or ptiO2
findings, the Friedman test of k dependent variables and/or the
Wilcoxon test of 2 dependent variables were used. Correlation
analyses were performed according to Spearman. p  0.05 was
chosen as the significance level. Statistical analyses were per-
formed using SPSS for Windows (SPSS, Surrey, UK).
FIGURE 1: X-ray topographic images and cranial computed tomography (CT) slices of Patients 1 and 2 with individual
locations of the electrocorticography (ECoG) strip electrodes (arrows, CT artifacts of electrodes) and the oxygen partial
pressure probes (arrowheads) adjacent to strip electrodes. Please note that levels of axial sections differ somewhat among
scans. The upper level shows Patient 1, with subarachnoid hemorrhage predominantly in the sylvian ﬁssure with additional
intraparenchymal hemorrhage and perifocal space-occupying edema. (A-D) A CT scan was performed after decompressive
craniectomy with ECoG and tissue oxygen pressure (ptiO2) probe implantation 2 days after subarachnoid hemorrhage (SAH).
(A) In the topogram, the arrows represent 6 single electrodes of the ECoG strip electrode. The arrowhead demarcates the
ptiO2 probe. (B) The arrow indicates electrode 2. (C) Arrows indicate electrodes 3 and 4, respectively. (D) The arrow
indicates electrode 5, and the arrowhead demarcates the ptiO2 probe. (E) Perfusion-weighted (PW) magnetic resonance
imaging (MRI) and (F) diffusion-weighted (DW) MRI show no perfusion deﬁcit or signs of cortical ischemia 4 days after SAH.
The area of intracranial hemorrhage displays disturbance of the diffusion signal. (G) PW MRI and (H) DW MRI demonstrate
areas of hypoperfusion and signs of cortical ischemia predominantly of the right frontal lobe, but also of the left frontal
lobe 9 days after SAH. (I) MRI (T1 weighted) shows infarcted cortical tissue. (J) A T2-weighted MRI cross-section (more
rostral) gives a detailed picture of the distribution of cortical infarcts with right frontoparietal and bifrontal representation.
The lower level shows Patient 2, who suffered a subarachnoid hemorrhage from a ruptured aneurysm, which was clipped
surgically 2 days after SAH. Cranial CT scan was performed 1 day after the craniotomy and ECoG and ptiO2 probe
implantation. (K) X-ray topogram and (K-M) 2 different slices are depicted. (K) Six arrows indicate the ECoG strip with 6
single electrodes. The arrowhead demarcates the ptiO2 probe. (L) The arrows indicate electrodes 1, 2, and 3; the arrowhead
indicates the ptiO2 probe between electrodes 2 and 3. (M) All 6 electrodes are displayed; however, the ptiO2 probe is not
visible on this cross section. (N) Seven days after SAH, PW MRI showed no hypoperfusion, and (O) DW MR imaging revealed
no signs of ischemia (disturbance of diffusion). (P) The same was true for the T1-weighted MRI and also (Q) for T2-weighted
MRI (see Supplementary Clinical Results online for a more detailed description of the 2 individual clinical courses).
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Patients Characteristics
A summary of patients’ clinical data is given in the Table.
Two patients developed DIND, and 7 did not. All 7 pa-
tients undergoing DS angiography or time of flight MRI
showed mild, moderate, or severe proximal vasospasm. In
Figure 1, imaging findings of a patient developing DIND
(Patient 1; see Fig 1A–J) are compared with those of a
patient developing no delayed cortical infarcts (Patient 2;
see Fig 1K–Q). Artifacts are seen, demonstrating the po-
sitions of subdural ECoG strip electrodes and adjacent
ptiO2 probes. See also Supplementary Clinical Results on-
line, especially for more detailed information on clinical
courses illustrating the entirely different ECoG and ptiO2
findings, and outcomes of these 2 patients.
Electrocorticogram
The total ECoG recording time in all patients amounted
to 850 hours, with a median recording time of 144 (82,
184) hours in individual patients. We found a total of
120 CSD events in 8 of 9 patients (89%). Fifty-five of
the 120 CSDs (46%) were found in the only 2 pa-
tients developing DIND, whereas a comparable number
of only 65 CSDs (54%) were found in 7 SAH patients
without delayed ischemia. In Patient 4, we were not able
to detect CSDs, possibly because of a suboptimal strip
electrode placement. Figure 2 shows an illustrative epi-
sode of a 4-channel (A-D) ECoG recording derived
from bipolar recordings between successive neighboring
electrodes 2 to 6 on the strip. The consecutive suppres-
sion in the high-pass filtered ECoG demonstrates the
propagation of the CSD wave from channel B to D (ar-
rows), whereas on channel A (recorded between elec-
trodes 2 and 3), only minimal activity is left, indicating
that electrodes 1 and perhaps 2 were positioned above
already injured and therefore depolarized tissue. ECoG
integral and power (see Fig 2A, lower panels) were cal-
culated, to optimize the determination of starting and
endpoints and thereby velocity and duration of CSD
waves. The propagation velocity of CSDs along the elec-
trode strip was 2.20 (1.34, 3.03) mm/min. CSD dura-
tion varied from 1 to 24 minutes, the median duration
being 7:46 (4:31, 12:30) minutes:seconds. Approxi-
mately 75% of all CSDs occurred between the 5th and
7th day after SAH (see Fig 2C). We identified in indi-
vidual patients a median number of 16 (9, 18) CSDs in
total and of 5 (0, 7) CSDs per day, thus documenting
FIGURE 2: Subdural electrocorticography (ECoG). (A) A representative electrocorticogram 5 days after subarachnoid hem-
orrhage (SAH) over a time period of 40 minutes (Patient 2). The upper 4 traces (channels A, B, C, and D) demonstrate the
high-passed ﬁltered ECoG data. The ECoG displays a cortical spreading depression (CSD, arrows) propagating from channel
B through C to D. The middle 4 traces show the integrals of each ECoG channel, with the corresponding integral changes
indicated with arrows. The lowermost 4 show the power of ECoG and the rapid reduction of power due to the CSD. Time
period from arrows to hash symbols represents the duration of the CSD
4; channel D shows the longest duration of this
typical CSD. Scales shown in channel D are also representative for the channels A, B, and C, respectively. (B) Schema of
ECoG electrode strip: 5 bipolar electrodes generate the 4 channels: A, B, C, and D. The 6th electrode can be used as
ground. (C) Histogram of CSD occurrence in SAH patients (n  8; for day 1, n  6) demonstrates that most CSDs (89 of
120 CSDs, 75%) occur between the 5th and 7th day after SAH.
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No. Age Gender Side Aneurysm Hunt

Hess
GCS WFNS Fisher IVH ICH Max
BFV
Prox VS
in DS-
A/(MR-A)
DIND eGOS
1 56 Female Right PcomA 4 3 5 3 Yes Yes 260 (Moderate) Yes 3
2 42 Female Right PcomA 3 13 1 3 No No 210 (Moderate) No 7
3 45 Male Right MCA 3 15 1 3 No Yes 120 (Mild) No 7
4 56 Female — AcomA 4 4 5 3 Yes Yes 200 — No 4
5 51 Female Right MCA 3 11 4 3 No No 150 Mild No 3
6 61 Female Right PcomA 4 3 5 3 No Yes 200 Moderate Yes 2
7 46 Female Right PcomA 2 15 1 3 Yes No 250 — No 6
8 68 Female Right ICA 4 3 5 3 No No 300 Severe No 6
9 56 Female Right MCA 4 4 5 3 No No 200 Moderate No 2
No.  patient number; Age  patient age in years; Gender  patient gender; Side  hemispheric location of ruptured
aneurysm; Aneurysm  vascular localization of ruptured aneurysm; HuntHess  initial neurological status according to Hunt
and Hess; GCS  Glasgow Coma Scale; WFNS  initial neurological status on the World Federation of Neurological Surgeons
scale; Fisher  computed tomography morphological classification of subarachnoid hemorrhage according to Fisher; IVH 
additional occurrence of intraventricular hemorrhage; ICH  additional occurrence of intracranial (parenchymal) hemorrhage;
Max BFV  maximal value of mean blood flow velocity in transcranial Doppler sonography (cm/s); DIND  delayed ischemic
neurological deficits, eGOS  extended Glasgow Outcome Scale 3 months after subarachnoid hemorrhage; PcomA  posterior
communicating artery; MCA  medial cerebral artery; AcomA  anterior communicating artery; ICA  internal carotid artery.
FIGURE 3: Coregistration of electrocorticography (ECoG) and tissue oxygen pressure (ptiO2). (A) A cluster of repetitive
cortical spreading depolarizations (CSDs) in association with transient biphasic ptiO2 responses demonstrated in the coreg-
istration of ECoG (lower line) and ptiO2 measurement (upper line) of a subarachnoid hemorrhage patient over a time period
of 10 hours (Patient 5). Channel D (integral [int.]) is shown. The 3 CSDs are marked by the arrows; arrowheads demonstrate
the corresponding biphasic ptiO2 responses. The long time period and the low baseline level of the ECoG integral reveal
the spatial and temporal association with ptiO2 responses. (B) The enlargement of temporal resolution of a certain time
period (rectangle in part A) and the addition of a second ECoG channel (C) (raw data and integral) reveal the exact CSD
propagation (arrows) from channel D to C and the clear temporal relationship with the corresponding biphasic ptiO2
response (arrowhead).
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appearance of CSDs as temporal clusters was predomi-
nant (80 [48, 95]%), particularly in SAH patients de-
veloping DIND (89 [80, 98]%).
Brain Tissue Partial Oxygen Pressure
During 90 of 120 CSD events, data were available from
ptiO2 probes implanted adjacent to the electrode strips,
yielding successful corecordings. In 53.3 (42.7, 67.1)% of
the coregistrations in individual patients, we observed ap-
parent spatial and temporal association between CSDs
and ptiO2 responses, the highest association being 90% in
1 individual. Figure 3A shows illustrative CSD waves in
an integrated ECoG channel (channel D) with simulta-
neously recorded biphasic ptiO2 changes, which were in
close temporal association with the identified CSDs. The
zoomed view (see Fig 3B, compare with rectangle in 3A)
reveals that the ptiO2 response is preceded by the CSD
wave on channel D, which then propagates to channel
C. The pattern of ptiO2 responses in the examples given
was biphasic, with a primary hypoxic phase followed by
a secondary, longer lasting hyperoxic phase. Monophasic
ptiO2 increases as well as decreases, however, were also
observed. Figure 4A depicts examples of these 3 different
types of ptiO2 responses. Figure 4B explains how we ex-
amined ptiO2 curves. The analysis revealed that most of
the recorded ptiO2 responses were biphasic. Monophasic
FIGURE 4: Three different types of tissue oxygen pressure (ptiO2) responses are found in the cortex of subarachnoid
hemorrhage (SAH) patients in spatial and temporal association with cortical spreading depolarizations (CSDs). (A) Biphasic
ptiO2 response with an initial decrease and a secondary increase, monophasic ptiO2 decrease, and monophasic ptiO2 in-
crease. Arrows indicate the start of CSD in the electrocorticography (ECoG) channel next to the ptiO2 probe. (B) Magniﬁ-
cation of the biphasic ptiO2 response of part A. Further detailed ptiO2 response analyses reveal values of speciﬁc features,
integrals, and subareas of the ptiO2-curve: BASE  ptiO2 at baseline (30.60 [25.25, 36.70] mmHg), MINhypo  the minimum
(23.90 [16.75, 32.38] mmHg), DURhypo  the duration (345 [207.5, 502.5] seconds), and INThypo  the integral (12.76 [3.87,
18.94] arbitrary units [aU]) of the initial hypoxic phase. descINThypo  (grey-shaded) integral representing the phase we
designate “descent area,” that is, the area under the curve from start to minimum of the hypoxic phase. MAXhyper  the
maximum (38.00 [28.30, 45.00] mmHg), DURhyper  the duration (720.0 [540.0, 1090.0] seconds), and INThyper  the integral
(40.00 [12.50, 124.28] aU) of the secondary hyperoxic phase; ascINThyper  second (grey-shaded) integral depicting an
ascent area, that is, the area from start to maximum of the secondary hyperoxic phase. In some cases (compare with Fig
4A), ptiO2 shows an asymptotic return to ptiO2 baseline, which may distort curve analysis; thus the grey-shaded areas are
additionally scrutinized to avoid this distortion. (C) Relative percentage frequencies of different ptiO2 responses to ECoG
events (90 CSDs). Clear spatial and temporal associations of ptiO2 responses with EcoG events are found in 53.3 (42.7,
67.1)% of the CSDs (in total 47 of 90 CSDs, with association rates up to 90% in single individuals). The differentiation of
all CSD-associated ptiO2 response types demonstrates that the biggest portion is contributed by biphasic ptiO2 responses
(Bi); monophasic increases (MI) were rare in the severe SAH patients, and monophasic decreases (MD) were more frequent.
(D) The 3 different ptiO2 responses (compare with part C) in total 100% and their distribution of SAH patients with no
ischemic neurological deﬁcit (DIND) (white bars) versus SAH patients with DIND (black bars). All monophasic ptiO2 increases
were found in SAH patients with no DIND and good outcome (extended Glasgow Outcome Scale > 6). Biphasic ptiO2
responses were approximately similar in both patient groups, whereas monophasic decreases were typically found in pa-
tients developing DIND.
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good outcome (extended Glasgow Outcome Scale
[eGOS] 6). Monophasic ptiO2 decreases were more
frequent. Approximately 70% of these decreases were
found in individuals who developed DIND in close
temporal association with the occurrence of CSD clus-
ters (see Fig. 4C,D).
Inﬂuence of Number and Frequency of CSDs
on CSD-Coupled ptiO2 Responses
In individual patients, both the absolute number and the
number/day of CSDs were positively correlated with the
duration of the hypoxic phase of biphasic CSD-associated
ptiO2 alterations (0.430, p  .005; 0.444, p 
.003, respectively), showing that primary hypoxia lasted
longer, if CSDs became more frequent. Conversely, the
absolute number of CSDs was negatively correlated with
the duration of the secondary hyperoxic phase of the
ptiO2 responses ( 0.408, p  .008). Thus the sec-
ondary, possibly compensatory hyperoxygenation declined
with increasing number of CSDs. Comparing primary
hypoxia with secondary hyperoxia (INThypo respectively
INThyper) in patients with and without DIND, we found
more pronounced hypoxic (19.90 vs 7.49 aU) and smaller
or no hyperoxic responses (0.51 vs 41.49 aU) in DIND
patients.
PtiO2 Response Alteration in CSD Clusters
The high incidence of CSD clusters (96/120 CSDs) in
general and particularly in DIND patients prompted us to
analyze additionally the temporal alteration of ptiO2 re-
sponses within clusters. These were defined by relatively
short intervals between consecutive CSDs (2 hours,
mean  standard deviation of all 96 CSDs within clusters:
44:14  21:15 minutes:seconds) and by small variations in
interval length (10%). We analyzed clusters with 4
events obtained in 5/8 patients by categorizing events by
their specific order as 1st, 2nd, 3rd, and 4th or higher rank
within clusters to study CSD-associated ptiO2 responses in
sequential order. Regarding biphasic ptiO2 responses in the
examples shown (Fig 5A, B: Patients 1 and 2, see also Sup-
plementary Clinical Results online), primary hypoxic de-
creases were enhanced within CSD clusters, whereas sec-
ondary hyperoxic increases appeared to be affected to a
lesser extent. Overall, primary hypoxic phases of the respec-
tive ptiO2 responses (descINThypo, see Fig 5D) were signif-
icantly augmented (n  5, p  0.011) within clusters,
whereas secondary hyperoxic phases (ascINThyper, see Fig
5E) did not show significant alterations. The ratio between
primary hypoxic and secondary hyperoxic phases (analyzed
as their respective subareas: descINThypo/ascINThyper) also
showed significant increases in successive events within
clusters (n  5, p  0.041). Considering all SAH patients
with clusters (including those with only 2 successive events
in some clusters), the comparison between hypoxic phases
(descINThypo) of the 1st versus the 2nd ptiO2 response
showed a trend toward enhanced hypoxic responses of the
2nd response within clusters (n  8, p  0.091). Summa-
rizing, prolonged clusters led to more pronounced and sig-
nificant changes of ptiO2 responses.
Unlike in the examples with progressive, stepwise
ptiO2 response modification, rapid, drastic alterations
from a biphasic to a monophasic ptiO2 decrease pattern
may occur, if a 2nd CSD quickly emerges before the pre-
vious ptiO2 response has returned to pre-event baseline.
In such a case (Fig. 5C), the hypoxic phase increased con-
siderably, and secondary hyperoxia was completely absent.
Discussion
Our study provides a unique insight into disturbed oxy-
gen availability to the SAH-injured human cerebral cortex
in association with CSD occurrence. Initially, the cortex is
not too seriously affected, but it may later develop cortical
microcirculatory vasospasm and increased O2 consump-
tion as responses to spontaneous CSD clusters. It would
now appear that delayed ischemic neurological deteriora-
tion may result not only from major proximal arterial va-
sospasm, but in addition from CSD clusters that in par-
ticular contribute to delayed ischemia by causing subtle
but noticeable stepwise alterations toward hypoxic tissue
conditions. In consequence, CSD clusters may play a cru-
cial role in the development of delayed ischemia after
SAH,
4,15,26 possibly in synergy with other mechanisms
known to affect SAH-injured tissue, such as inflammation,
blood–brain barrier disruption with edema formation and
resulting mass effects, and endothelial dysfunction and
thromboembolism.
1,27,28 Thus the demonstration that
CSD clusters occur and can reduce brain ptiO2 may go
some way toward explaining the variable association of de-
layed ischemia with proximal arterial vasospasm,
29 and the
existence of such a dual mechanism of delayed isch-
emia.
4,15,16
We detected CSD-associated ptiO2 alterations in
53% of CSDs despite an electrode to ptiO2 probe dis-
tance of 8mm and despite the fact that the effective
cortical area sampled by an ECoG electrode records
amounts to 250mm
2, whereas the ptiO2 probe analyzes
only an area of 7.1 to 15mm
2, comprising both cortical
and subcortical tissue.
24 In individual patients, we found
an incidence of CSD–ptiO2 associations of up to 90%,
demonstrating that CSD-associated ptiO2 changes are
common and therefore a relevant pathophysiological fac-
tor in cortical tissue of SAH patients. Moreover, it gives
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May, 2010 613FIGURE 5: Cortical spreading depolarization (CSDs) within clusters and corresponding tissue oxygen pressure (ptiO2) responses.
(A) An example (taken from Patient 1, 6 days after subarachnoid hemorrhage [SAH]) of 4 repetitive CSD-associated ptiO2
responses within a cluster (arrows in A–C represent start of CSD). The 1st ptiO2 response was biphasic, the 2nd and 3rd showed
stepwise augmentation of primary hypoxic phases of the ptiO2 responses with subsequent small or almost nonexisting secondary
hyperoxic phases, and the 4th showed a drastically enlarged hypoxic phase. Please note that particularly in the 4th ptiO2
response, the baseline level was not restored. This example shows an immediate transition from a biphasic to a monophasic
decrease pattern of the ptiO2 response and may therefore reveal a change from normal to inverse neurovascular coupling and/or
increased oxygen consumption, with the likelihood of secondary cortical ischemia after SAH. (B) The second example (taken from
Patient 2, 7 days after SAH) of 4 repetitive CSD-associated ptiO2 responses within a cluster (arrows, see above). The primary
hypoxic phases were stepwise slightly enlarged beginning with the 1st, then the 2nd, 3rd, and 4th response; however, a similar
extension was seen in the secondary hyperoxic phases. In this example, all ptiO2 responses were biphasic in nature, and the ptiO2
baseline level was subsequently reestablished or even slightly exceeded, possibly representing normal (compensatory hyperemic)
neurovascular coupling and/or simply transiently increased oxygen consumption not leading to ischemic transformation after SAH.
(C) Examples of 2 CSD-associated ptiO2 responses with a rapid sequence of CSDs. Note that the period from 1st to 2nd CSD
lasts only 12 minutes. The ﬁrst ptiO2 response showed a biphasic pattern with a small hypoxic and a relatively large secondary
hyperoxic phase, whereas the 2nd response revealed a deeper and prolonged hypoxic phase without a secondary hyperoxic
phase, that is, a monophasic decrease of ptiO2. This example demonstrates a rapid transition from biphasic to monophasic decreasing
ptiO2 pattern, perhaps due to the very small period between 2 repetitive CSDs. (D, E) Analysis of CSDs and corresponding ptiO2
responses within clusters. Box plots represent CSDs categorized by their speciﬁc order (1st, 2nd, 3rd, and >4th) showing median,
quartiles, and full range of data. CSD-associated hypo- and hyperoxic ptiO2 response phases (areas of descINThypo or ascINThyper, see
Fig 4B) are shown. With ascending order of CSDs within the clusters (D) areas of the initial hypoxic phase increased signiﬁcantly in a
stepwise fashion within clusters (n  5, p  0.011, Friedman test). (E) Areas of the secondary hyperoxic phase showed no signiﬁcant
alterations (n  5, not signiﬁcant); however, CSDs >4th in a cluster suggested a trend to higher areas. aU  arbitrary units.
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sociated microcirculatory disturbance
15 may not be re-
stricted to cortical tissue. Occasional lack of ptiO2 re-
sponse association in individual patients with some
successive CSDs may be explained by varying routes of
CSD wave propagation,
9,10,19 if the waves were for exam-
ple induced at different sites and came into the rather
large effective detection range of the ECoG electrode but
not into the smaller range of the ptiO2 probe.
The propagation velocity of CSDs was comparable
with Lea ˜o’s classical description
5 and recent clinical stud-
ies.
4,9,10 The rate of CSD initiation peaked at days 5 to 7
after SAH (see Fig 2C), suggesting a possible role of CSD
in DIND development, which has been reported to occur
within approximately the same time frame.
1,23 Other
pathophysiological mechanisms develop earlier
1,30 or at
more or less unpredictable time points after SAH.
1 Be-
cause 89% of CSDs arose within clusters in DIND pa-
tients, and because clusters altered ptiO2 responses in par-
ticular, we consider that these clusters may also play a role
in DIND evolution. In contrast, single CSDs may be less
harmful.
12 The high incidence of CSD clusters in our se-
vere SAH patients is comparable with other conditions
requiring neurocritical care and exhibiting secondary isch-
emic deterioration, such as malignant hemispheric
stroke.
10
How might CSD clusters contribute to secondary
injury progression after SAH? Experimental and clinical
evidence demonstrates that CSD does not invariably in-
duce compensatory vasodilatation (normal neurovascular
coupling, as is known for physiological perfusion condi-
tions), but can instead induce vasoconstriction (inverse
coupling) if tissue conditions are unfavorable.
5,15,16,31,32
In an SAH model,
16 it was shown initially that inverse
neurovascular coupling led to widespread focal infarcts.
Inverse coupling was likewise found during hypoxia or
systemic hypotension, and in the boundary zones of focal
ischemia after middle cerebral artery occlusion.
18–20 It is
well known that ptiO2 is mostly linked to regional
CBF.
15,24,25,33,34 The variable ptiO2 responses found in
our SAH patients (see Fig 2A, C) resemble the patterns of
CBF responses coupled to CSD/PID described in ani-
mals.
16,19,20 Most of the ptiO2 responses examined were
biphasic in nature (see Fig 2C), resembling biphasic CBF
response patterns in boundary zones of ischemic
foci
19,32,35; hence, we infer that our recordings were per-
formed largely in metabolically disturbed but not yet se-
verely injured tissue compartments. Monophasic hypoxic
episodes indicate altered or missing secondary, compensa-
tory hyperoxic phases, worsening in vascular reactivity,
and thus deterioration of tissue conditions.
It seems, therefore, that the complex antagonism be-
tween vasoconstrictive and vasodilator mechanisms after
SAH
36 is progressively disturbed during ongoing CSD ac-
tivity. Various intra- and extracellular mechanisms influ-
encing coupled responses have been reported, some lead-
ing to intracellular calcium ([Ca
2]i) accumulation in
smooth muscle cells.
36,37 Repetitive CSDs may support
this [Ca
2]i accumulation and promote microvascular
spasm and NO resistance.
38 Other putative mechanisms
may include activation of matrix metalloproteinase-9 fol-
lowed by dysfunction of the neurovascular unit.
39 As a
mechanistic explanation for DIND, CSI has recently at-
tracted interest.
1,4,11,40 It has been shown that in the pres-
ence of elevated extracellular potassium concentration
([K
]e), depletion of NO may alter the vasomotor re-
sponse to CSD from vasodilatation to vasoconstriction,
resulting in ischemic transformation.
16,32,35 Elevated
[K
]e generally characterizes any state of energy shortage.
The vasoconstrictor capacity of [K
]e easily dominates
SAH tissue, because NO is trapped by the potent NO
scavenger hemoglobin, both hemoglobin and K
 being
released from erythrocytes in the subarachnoid space after
SAH. Vasoconstriction then worsens energy delivery to
this tissue, and in turn, K
 release is enhanced, creating a
vicious cycle that inhibits repolarization and augments
ischemia. CSD clusters with repetitive neuronal and as-
trocytic de- and repolarizations will reinforce such a cycle,
as does repetitive vasoconstrictive activation of smooth
muscle cells, which also utilize adenosine triphosphate
(ATP) and O2. Accordingly, an altered metabolic state
has been described for perivascular sites during CSD.
41
Smooth muscle relaxation, as a component of vasodilata-
tion, also requires ATP (flexibilizer function of ATP). In
the case of repetitive CSDs with ATP depletion due to
ATP-depended vascular responses
18,19 and multiple neu-
ronal and astrocytic repolarizations,
7–9 the relaxation
component of vasodilatation may therefore be negatively
influenced. Furthermore, adenosine, a potential vasodila-
tor and a metabolite of ATP degradation present in met-
abolically disturbed tissue, failed to improve vasodilata-
tion after CSDs.
32 Hence, CSD clusters may provoke
repetitive vasoconstriction
19 with gradually decreasing
likelihood of vasodilatation, and progressively modified
ptiO2 responses may finally result in cortical microvaso-
spasm. Delayed laminar infarction in cortex, as found
typically in SAH patients, supports this interpretation.
38
Because in our study hypoxic portions of the CSD-
associated ptiO2 response increased, and hyperoxic por-
tions decreased or were completely absent after recurrent
CSDs (see Fig 5), we assume that a rapid sequence of
CSDs generates a vulnerable phase that potentiates hy-
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essary to understand the complexity of delayed ischemia
after SAH and the role of CSD clusters for this compli-
cation. The likely role of clusters in degrading tissue of
marginal viability is illustrated by the detection with rapid
sampling microdialysis of stepwise depletion of cortical
tissue glucose during a cluster of CSDs.
42
PtiO2 recordings inevitably reflect both delivery and
consumption of tissue oxygen.
24,34 CBF alterations linked
to CSD have recently been shown to correlate with ptiO2
changes.
15 CSD—more specifically, repolarization of neu-
ronal membrane potentials—markedly increases energy
metabolism
7–9,13 and depletes brain glucose.
40,42 Com-
plete loss of compensatory vasoreactive power would re-
sult in sustained reduction of CBF and/or ptiO2 to zero,
19
reflecting spreading ischemia.
15,16,19 We were not able to
observe such a phenomenon by ptiO2 monitoring in our
study, presumably because only by chance, recordings
with strip electrodes positioned at only 1 site in the sur-
rounding of SAH would pick up the phenomenon. Ret-
rospective analysis of imaging results revealed that ptiO2
probes were never positioned in tissue compartments un-
dergoing delayed ischemia, offering an explanation for the
lack of sustained ptiO2 reduction. Responses with long
monophasic ptiO2 reductions found particularly in DIND
patients may be interpreted as a preliminary stage of such
delayed, terminal transformation as seen in spreading
ischemia.
15,16,19,35 It is obvious that recordings at only 1
location are suboptimal regarding a comprehensive analy-
sis of the surroundings of injuries, and multiple site ptiO2
measurements would therefore be favorable but difficult
to perform. A further limitation of the study is the lack of
adequate and frequent imaging techniques like MRI
(perfusion-weighted imaging, diffusion-weighted imaging)
for the possible detection of spreading ischemia as shown
in our examples. Logistic reasons and intensive care made
this management impossible in some patients of our
study. The COSBID plans a multicenter study that aims
at following such sequential imaging protocol in all pa-
tients. In this study, we also aim to test intrinsic neuro-
vascular function and the capacity for local cerebrovascu-
lar autoregulation and oxygen reactivity,
1 because these
factors may be of relevance for the biphasic ptiO2 cycle.
In conclusion, CSDs may impair microvascular
function and O2 availability, likely with increased O2
consumption, in human cerebral cortex after SAH, espe-
cially if they occur in clusters. Our results indicate that
this is related to secondary hypoxic transformation and
the likelihood of DIND. The correspondence of experi-
mental and clinical data suggests that we can now cau-
tiously translate the well-known impact of depolarizations
on pathophysiological outcome in experimental models
into the clinical situation. Considering the importance for
outcome of secondary deterioration in SAH, CSD may
represent a promising target for therapeutic intervention
to improve poor outcome and mortality after SAH.
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